Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy comprising compounds of formula (I) and GLP-1 receptor agonists

Combination therapy comprising compounds of formula (I) and GLP-1 receptor agonists

US Patent 12458612 · Granted Nov 4, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Phosphate derivatives of RORgamma modulators and uses thereof2025
Combination of nitazoxanide and elafibranor for the treatment of immune diseases2025
Pharmaceutical compositions for combination therapy2024
RORgamma modulators and uses thereof2024
Pharmaceutical compositions for combination therapy2023
Pharmaceutical compositions for combination therapy2023
Combination comprising a PPAR agonist such as elafibranor and an acetyl-CoA carb2022
Combination comprising a PPAR agonist such as elafibranor and an acetyl-CoA carb2022
Combination comprising a PPAR agonist such as elafibranor and an acetyl-CoA carb2022
Combination of Elafibranor or derivatives thereof with an anti-NASH, anti-fibrot2022
Combination of Elafibranor or derivatives thereof with an anti-NASH, anti-fibrot2022
Combination of Elafibranor or derivatives thereof with an anti-NASH, anti-fibrot2022